One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Abstract Objectives To explore the frequency and predictors of flares over 2 years during a treat-to-target strategy with urate-lowering therapy (ULT) in patients with gout. Methods In the treat-to-target, tight control NOR-Gout study patients started ULT with escalating doses of allopurinol. Flares...

Full description

Bibliographic Details
Main Authors: Till Uhlig, Lars F. Karoliussen, Joe Sexton, Tore K. Kvien, Espen A. Haavardsholm, Fernando Perez-Ruiz, Hilde Berner Hammer
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Arthritis Research & Therapy
Subjects:
Gout
Treat to target
Flare
Urate lowering treatment
Predictor
Online Access:https://doi.org/10.1186/s13075-022-02772-3

Internet

https://doi.org/10.1186/s13075-022-02772-3

Similar Items